Format

Send to

Choose Destination
J Am Acad Dermatol. 2014 Dec;71(6):1077-82. doi: 10.1016/j.jaad.2014.08.026. Epub 2014 Oct 11.

Clinical characteristics associated with Spitz nevi and Spitzoid malignant melanomas: the Yale University Spitzoid Neoplasm Repository experience, 1991 to 2008.

Author information

1
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut; Section of Dermatology, Veterans Administration Connecticut Healthcare System, West Haven, Connecticut.
2
Department of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
3
University of Southern California, Keck School of Medicine, Los Angeles, California.
4
Yale Cancer Center, New Haven, Connecticut; Section of Plastic and Reconstructive Surgery, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut.
5
Yale Cancer Center, New Haven, Connecticut; Section of Medical Oncology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
6
Yale Cancer Center, New Haven, Connecticut; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut. Electronic address: rossitza.lazova@yale.edu.

Erratum in

  • J Am Acad Dermatol. 2015 Apr;72(4):748.

Abstract

BACKGROUND:

Spitz nevi and Spitzoid malignant melanomas are uncommon and may be difficult to distinguish histopathologically. Identification of clinical features associated with these lesions may aid in diagnosis.

OBJECTIVE:

We sought to identify clinical characteristics associated with Spitz nevi and Spitzoid malignant melanomas.

METHODS:

We conducted a retrospective cohort study of Spitz nevi and Spitzoid malignant melanomas from the Yale University Spitzoid Neoplasm Repository diagnosed from years 1991 through 2008. Descriptive statistics and multivariate logistic regression were used to compare select patient- and tumor-level factors associated with each lesion.

RESULTS:

Our cohort included 484 Spitz nevi and 54 Spitzoid malignant melanomas. Spitz nevi were more common (P = .03) in females (65%; n = 316) compared with Spitzoid malignant melanomas (50%; n = 27), occurred more frequently in younger patients (mean age at diagnosis 22 vs 55 years; P < .001), and more likely presented as smaller lesions (diameter 7.6 vs 10.5 mm; P < .001). Increasing age (odds ratio 1.16, 95% CI [1.09, 1.14]; P< .001) and male gender (odds ratio 2.77, 95% CI [1.17, 6.55]; P< .02) predicted Spitzoid malignant melanoma diagnosis.

LIMITATIONS:

Small sample size, unmeasured confounding, and restriction to a single institution may limit the accuracy and generalizability of our findings.

CONCLUSIONS:

Age and gender help predict diagnosis of Spitz nevi and Spitzoid malignant melanomas.

KEYWORDS:

Spitz nevus; Spitzoid malignant melanoma; Yale Spitzoid Neoplasm Repository; clinical characteristics; diagnosis; epidemiology

PMID:
25308882
PMCID:
PMC6133655
DOI:
10.1016/j.jaad.2014.08.026
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center